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Abstract 
Objective: In a recent genome-wide association study of subcortical brain volumes,1 
we have identified common genetic variation at rs945270 as having the strongest 
effect on putamen volume, a brain measure linked to familial risk for 
attention-deficit/hyperactivity disorder (ADHD). To determine whether rs945270 is a 
genetic determinant of ADHD, we now explored it impacts on ADHD-related 
symptoms and on neural mechanisms of ADHD, such as response inhibition and 
reward sensitivity.  
Method: We used a large population sample of 1,834 14-years old adolescents to test 
the effects of rs945270 on (i) ADHD symptoms accessed through the Strengths and 
Difficulties Questionnaire (SDQ) and (ii) Region-of-interest (ROI) analyses of 
putamen activation by functional magnetic resonance imaging (fMRI) using the Stop 
Signal (SST) and monetary incentive delay (MID) tasks, assessing response inhibition 
and rewards sensitivity, respectively.  
Results: We found a significant link between rs945270 and ADHD symptoms scores, 
the C-allele being associated with lower symptoms scores, most notably hyperactivity. 
We also observed sex-specific effects of this variant on the brain. In boys, the C-allele 
associated with lower putamen activity during successful response inhibition, a brain 
response that was not associated with ADHD symptoms. In girls, putamen activation 
during reward anticipation increased with the number of C-alleles, most significantly 
in the right putamen. Remarkably, right putamen activation during reward 
anticipation tended to negatively correlate with ADHD symptoms. 
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Conclusions: Our results indicate that rs945270 may contribute to the genetic risk of 
ADHD partly through its effects on hyperactivity and reward processing in girls. 
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Introduction 
Abnormalities in subcortical brain structures, notably in the putamen 2, 3 have been 
linked to Attention-deficit/hyperactivity disorder (ADHD), a highly heritable and 
multifactorial neurodevelopmental disorder characterized by symptoms of inattention 
and hyperactivity/impulsivity,4. The age-dependent reductions in putamen volume 
that normally occur during childhood throughout early adulthood are not observed in 
ADHD patients and their non-affected siblings,5, 6 suggesting that heritable 
differences in developmental putamen trajectories contribute to the risk for ADHD. 
Thus, the examination of individual differences in ADHD-related measures including 
the putamen, in a nonclinical sample of youth may provide valuable insight into the 
disease. 
	  
That abnormalities within the putamen contribute to the pathology of ADHD is 
further supported findings showing that lesions of the putamen tend to associate with 
ADHD symptomatology 7, 8. Functional neuroimaging approaches have been helpful 
in identifying the neural mechanisms underlying ADHD symptoms. Task-based fMRI 
studies have shown that ADHD associates with poor response inhibition (i.e., a deficit 
in the ability to stop an already planned or initiated action), due to abnormalities in 
frontal-striatal and frontal-parietal networks in adolescents and young adults with 
ADHD,9-11 which may underlie some of the deficits in impulse control observed in 
ADHD 12. On the other hand, several fMRI studies have observed decreased 
activation of the ventral striatum – an area including the ventromedial putamen 13 
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during anticipation of reward in both adolescents and adults with ADHD, which led to 
the hypothesis that ADHD is part of a reward deficiency syndrome reflecting the 
impact of dysregulation of dopamine on the reward system 14, 15. Despite evidence 
implicating the putamen in the pathology of ADHD, its distinctive contributions in the 
neurobiology of ADHD remains understudied, possibly because, small subcortical 
brain regions like the putamen are relatively difficult to observe in whole brain fMRI.  
  Progress to identify genetic factors contributing to putamen development was made 
through our recent genome-wide meta-analysis that identified several single 
nucleotide polymorphisms (SNPs) associating with subcortical regions, with the 
strongest effects observed for rs94527 on the volume of the putamen. Genotypes at 
this SNP appear to have functional consequences as the C-allele at this locus, which 
associates with increased putamen volume, also associates with increased expression 
of the nearby KTN1 gene in brain and in blood1. This gene is known to play a role in 
intracellular organelle motility and it is interesting to note that its expression was 
found to be decreased in patients with Parkinson's disease 16 and in depressed women 
undergoing antidepressant-treatment 17. Results of these analyses also indicated that 
while rs945270 associated with putamen volume across the lifespan, the effects of this 
SNP on putamen volume tended to decrease with the mean age of each participating 
cohort1. This, and the age-dependent reductions of putamen volume from childhood 
through early adulthood in controls but not in individuals with ADHD or their 
unaffected siblings6, suggested that rs945270’s effect on the putamen might 
predispose to ADHD. 
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 To test this, we analyzed the effects of rs945270 on putamen function and its relation 
to ADHD-related phenotypes in a large healthy cohort of 14-year-old adolescents, 
using the Stop-Signal (SST) and the Monetary-Incentive-Delay (MID) fMRI tasks 
that assess motor control and reward processing, respectively.  
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Method 
Participants 
Participants of the study were tested at eight assessment centres (London, Nottingham, 
Dublin, Mannheim, Berlin, Hamburg, Paris, and Dresden). Local ethics research 
committees at each site approved the study. On the day of assessment, written consent 
was obtained from the parent or guardian, and verbal assent was obtained from the 
adolescent. A detailed description of the recruitment and assessment procedures and 
inclusion/exclusion criteria have been published elsewhere 18. After quality control, 
complete and reliable datasets were available from 1129 participants during the 
reward anticipation phase of the monetary incentive delay task (MID), and from 1227 
participants for the successful inhibition in the stop signal task (SST). Demographics 
information is displayed in Table 1.  
ADHD Symptoms (Strength and Difficulties Questionnaire) 
ADHD symptoms were assessed using parental reports of the Strength and 
Difficulties Questionnaire (SDQ), a 25-item behavioral screening tool probing for 
ADHD-type problems (hyperactivity, inattention, and impulsivity), emotional 
symptoms, conduct problems, peer problems, and prosocial behavior 19. For this study, 
we used the SDQ ADHD symptoms scale, which provides a sum score (ranging from 
0 to 10) for both hyperactivity/impulsivity (with a 3-items subscale, with scores 
ranging from 0 to 6) and inattention (with a 2-items subscale, scores ranging from 0 to 
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4). The Development and Well-Being Assessment (DAWBA) 20 was also used to 
administer a structured interview to parents and children, which was used by 
experienced clinical raters to assign DSM-IV diagnoses, blind to the SDQ scores. 
Genotyping and quality control 
DNA purification and genotyping was performed by the Centre National de 
Génotypage in Paris. DNA was extracted from whole blood samples preserved in 
ethylene-diamine-tetra-acetic acid (EDTA) vacutainer tubes (BD, Becton, Dickinson 
and Company, Oxford, United Kingdom) using the Gentra Puregene Blood Kit 
(QIAGEN, Valencia, California) according to the manufacturer’s instructions. 
Genotype information was collected at 582,982 markers using the Illumina 
HumanHap610 Genotyping BeadChip (Illumina, San Diego, California)  18. A total 
of 705 and 1382 individuals were genotyped with the Illumina (Little Chesterford, 
UK) Human610-Quad Beadchip and Illumina Human660-Quad Beadchip, 
respectively. Single-nucleotide polymorphisms (SNPs) with call rates <98%, minor 
allele frequency <1%, or deviation from the Hardy–Weinberg equilibrium (P <1 × 
10−4) were excluded from analyses. Individuals with an ambiguous sex code, 
excessive missing genotypes (failure rate >2%), and outlying heterozygosity 
(heterozygosity rate of 3 SDs from the mean) were also excluded. Identity by state 
similarity was used to estimate cryptic relatedness for each pair of individuals using 
the PLINK software (pngu.mgh.harvard.edu/∼purcell/plink/). Closely related 
individuals with identity by descent >0.1875 were eliminated from the subsequent 
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analysis. Population stratification for the GWAS was examined using 
multi-dimensional scaling (MDS) analysis with HapMap populations as reference 
groups. Individuals with divergent ancestry (from Utah residents with ancestry from 
northern and western Europe) were excluded through visual inspection of the first two 
components. Supplementary Figure S1 shows that our sample is genetically 
homogeneous (overlapping with the CEU population). The imputation protocol used 
MaCH sofware for haplotype phasing and minimac for imputation 21.  
MRI Data Acquisition and Preprocessing 
MRI data were acquired with 3T MRI scanners of different manufacturers (Siemens, 
Munich, Germany; Philips, Best, The Netherlands; General Electric, Chalfont St Giles, 
UK; Bruker, Ettlingen, Germany) using the same scanning protocol at all sites (see 
SI). High-resolution T1-weighted 3D structural images were acquired for anatomical 
localization and coregistration with the functional time series. Forty slices, tilted to 
the anterior-posterior commissure line, were acquired in descending order (2.4 mm 
thickness, 1 mm gap) using a gradient-echo T2*-weighted echo-planar imaging (EPI) 
sequence, and the following parameters: TR = 2200 ms; TE = 30 ms; matrix size 
64 × 64 over a 21.8-cm field of view, giving an in-plane resolution voxel size of 
3.4 × 3.4 mm. For anatomical reference, a 3D gradient echo-based sequence of the 
whole brain was obtained, using protocol based on the Alzheimer's Disease 
Neuroimaging Initiative (ADNI) protocol 
(http://www.loni.ucla.edu/ADNI/Cores/index.shtml). 
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  fMRI data were analyzed with SPM8 (Statistical Parametric Mapping, 
http://www.fil.ion.ucl.ac.uk/spm). Spatial preprocessing included: slice time 
correction to adjust for time differences due to multi-slice imaging acquisition, 
realignment to the first volume in line, non-linearly warping to the MNI space (based 
on a custom EPI template (53x63x46 voxels) created out of an average of the mean 
images of 200 adolescents), resampling at a resolution of 3x3x3mm3 and smoothing 
with an isotropic Gaussian kernel of 5 mm full-width at half-maximum. At the first 
level of analysis, changes in the BOLD response for each subject were assessed by 
linear combinations at the individual subject level, for each experimental condition, 
each trial (e.g., anticipation of high gain in the MID task) was convolved with the 
hemodynamic response function to form regressors that account for potential noise 
variance, e.g. head movement. Estimated movement parameters were added to the 
design matrix in the form of 18 additional columns (3 translations, 3 rotations, 3 
quadratic and 3 cubic translations, and each 3 translations with a shift of ±1 TR). 
  We extracted the putamen ROI using the Marsbar toolbox 
(http://marsbar.sourceforge.net), based on the Montreal Neurological Institute 
Automated Anatomical Labeling. Averaged beta values based on all voxels in the left 
and right putamen were used for ROI analyses. The current study used the contrast 
‘successful stop vs. successful go trials’ to access brain activity associated with 
inhibition of a motor response in the SST. For the MID task, we used the contrast 
‘anticipation of high win vs. anticipation of no win’ based on prior research 
suggesting reliable associations between ADHD-symptoms and fMRI BOLD 
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responses measured during reward anticipation 22. 
Monetary Incentive Delay Task 
To examine neural responses to reward anticipation and outcome, participants 
performed an age-adapted version of the Monetary Incentive Delay (MID) task 23 in 
which sweets instead of money were used as reward.  It is a reaction time task that 
assesses how quickly the subject press a button with left or right index finger to hit a 
target (white square) that only appears for a short time on the left or right side of the 
screen.   
Stop Signal Task 
The stop signal task (SST) was used to study neural responses to successful and 
unsuccessful inhibitory control 24. Participants were instructed to make a single, 
button-press response to either of two regularly presented, visual-go stimuli (arrows 
pointing left or right shown centrally for 1000ms), unless followed by an 
unpredictable stop signal (arrow pointing upwards shown for 100–300 ms). Twenty 
percent of the go stimuli were followed by a stop signal. The dependent variable of 
the task is the stop signal reaction time (SSRT), which was calculated by subtracting 
the mean stop signal delay (the average time between go and stop signal, at which the 
subject managed to inhibit to 50% of trials) from the mean reaction time to go trials 25. 
Because of problems in the tracking algorithm, SSRT data was only available for half 
of subjects (see SI). Participants had first completed a practice session outside the 
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scanner (for ~5 minutes).  
Statistical Analyses 
The general linear model was used to calculate associations between ADHD symptom 
scores, BOLD responses, behavioral measures and genotype, controlling for 
covariates of sex (depending on the analyses), scanning sites (7 dummy variables) and 
handedness. All analyses were two-sided. Since those hypotheses for brain activity 
involved the two hemispheres and two contrasts, the significance threshold was set to 
0.0125 using Bonferroni correction. 
To investigate the stability of our main findings, we have carried out two internal 
replications. First, we tested the same association in eight research sites separately. 
The regression coefficients (𝛽) and their corresponding Standard Errors (SEs) were 
then used to conduct a meta-analysis. The R package rmeta 
(https://cran.r-project.org/web/packages/rmeta/ rmeta.pdf) was then used to generate 
the forest plot. Second, a resampling of the original data with replacement (a 
bootstrapping process) was conducted to generate a new sample with the same sample 
size as the original data. The process was replicated 10000 times, and all of the t 
statistics were used to calculate a bootstrapping p-value. By these two replications, we 
demonstrated both the stability of the results and the fact that they are unlikely to 
reflect sample specific variance.  
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Results 
Relationship of rs945270 with ADHD symptoms 
In our population cohort of 14-year-old adolescents, each copy of the C allele was 
associated with a 77.4 mm3 increase in the averaged volume of the bilateral putamen 
(𝛽 = 77.4, 1.1% variance explained, p = 1.3 x 10-5). While we noted a sex difference 
for putamen volume (smaller volume in girls than in boys: 𝛽= -554.5, p < 10-10), there 
were no interaction between sex and genotype at rs945270 on putamen volume (𝛽 = 
-16.1, p = 0.65). Investigating the relationship between rs945270 and ADHD 
symptoms, we found that rs945270 significantly associated with ADHD symptoms in 
the full sample. The C-allele at rs945270 associated with lower scores for ADHD 
symptoms compared to the G-allele, such that each C-allele is expected to reduce 
symptoms scores by 0.067 standard deviation (𝛽  = -0.21, 𝛽stand = 0.067, p = 0.0053; 
bootstrapping:  p = 0.0070; meta-analysis: 𝛽  = -0.21, p = 0.0063; Figure 1 and Table 
2). Testing for the specificity of rs945270 on ADHD symptoms, we found that 
variation at rs945270 was mostly associated with hyperactivity symptoms (𝛽  = 
-0.126, 𝛽stand = -0.065, p = 0.0054 and 𝛽 = -0.093, 𝛽stand = -0.051, p = 0.028 for the 
hyperactivity and inattention subscales, respectively). Testing for possible sex 
differences in ADHD symptoms, we found that girls scored lower for ADHD 
symptoms than boys (𝛽 = -0.77, βstand = -0.169, p = 1.12 x 10-12), differing relatively 
more in inattentive (𝛽 = -0.406, βstand = -0.162, p = 6.77 x 10-12) than in hyperactive 
(𝛽 = -0.361, βstand = -0.134, p = 1.37 x 10-8) symptoms. There was no sex-by- 
rs945270 genotype interaction on ADHD symptoms (𝛽  = 0.049, p = 0.71). ADHD 
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symptoms scores were not associated with putamen volume in this sample (𝛽 = 
-0.00012, p = 0.28); the association between rs945270 genotypes and ADHD 
symptoms remained significant after controlling for the whole putamen volume. 
Testing for the specificity of rs945270 effects, we analyzed its association with the 
other four symptoms domains measured by the SDQ. We found nominal association 
of rs945270 with the emotional symptoms score (𝛽 = -0.15, p = 0.021), not with the 
conduct (𝛽 = -0.048, p = 0.37), peer problem (𝛽 = -0.074, p = 0.17) and prosocial (𝛽 
= 0.075, p = 0.21) scores. 	  
As about 2.5% of our sample had received a diagnosis of ADHD (11 girls and 35 
boys), based on the DAWBA 20, we tested how well the SDQ symptoms scores 
correlated with the ADHD diagnosis. There was a moderate positive correlation (β = 
0.304, p = 4.23 x10-40) between the two variables, confirming the utility of the SDQ 
as a screening tool for ADHD in the community 26. 
 
Response Inhibition 
We next tested the effects of rs945270 on inhibitory control, assessing 
blood-oxygen-level dependent (BOLD) responses in the putamen during successful 
inhibition of motor response in the SST fMRI task. The C-allele of rs945270 
associated with decreased putamen activity (left putamen: 𝛽  = -0.088, p = 0.0030; 
bootstrapping p = 0.0060; meta-analysis, 𝛽  = -0.080, p = 0.0039; right putamen: 𝛽  = 
-0.089, p = 0.0018, bootstrapping p = 0.0020; meta-analysis, 𝛽  = -0.094, p = 0.0016) 
in the full sample (Table 3). Girls had lower BOLD-responses than boys, most 
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significantly in the left putamen (left: 𝛽  = -0.15, p = 0.002; right: 𝛽  = -0.084, p = 
0.035), and we observed a significant sex-by-genotype interaction in the left (𝛽 = 
0.16, p = 0.0080; bootstrapping p = 0.0080; meta-analysis 𝛽 = 0.17, p = 0.013), but 
not in the right putamen (𝛽  = 0.087, p = 0.12) (Table 3). Sex-specific analyses 
indicated that the associations of rs945270 with putamen activity observed in the full 
sample were mainly driven by boys; the C-allele was associated with decreased 
putamen activation in this group (left putamen: 𝛽  = -0.16, p = 0.0005; right putamen: 𝛽  = -0.13, p = 0.004), but not in girls (left putamen: 𝛽  = -0.010, p = 0.78; right 
putamen: 𝛽  = -0.047, p = 0.20) (Figure 2A,B). To test if these effects of rs945270 on 
putamen activation in boys were localized rather that distributed throughout the whole 
putamen, we performed post-hoc, voxel-wise association within the putamen. These 
revealed significant clusters of activity only in the right putamen, in caudal regions 
(Supplementary Figure S2, Table S1). This suggests that rs945270 influences 
response inhibition in boys throughout global rather than localized effects on the left 
putamen. Although we observed significant negative association between putamen 
volume and left putamen activation in the full sample (left: 𝛽 = -0.000093, p = 0.018, 
right: 𝛽 = -0.000063, p = 0.12), the association between genotype and putamen 
activation remained significant after controlling for putamen volume. However, while 
rs945270 variation associated with putamen activation during successful inhibition in 
boys, we found no significant association between putamen activation and ADHD 
symptoms, neither in the full sample (Table 3) nor when analyzing boys only (left: 𝛽 
= 0.16, p = 0.19, right: 𝛽 = 0.10, p = 0.43). This indicates differences in putamen 
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activation during successful inhibition are unlikely to account for the association 
between rs945270 and ADHD symptoms noted above. 
To test if these differences in putamen activation were reflected at the 
behavioural level, we analyzed a subsample of N = 671 individuals with information 
on duration of the stop process (SSRT), a known proxy for ADHD symptoms that 
also correlated with ADHD symptoms scores in our sample (𝛽 = 1.44, p = 0.014). 
Putamen activation during successful stopping negatively correlated with SSRT in the 
full sample (left: 𝛽 = -12.28, p = 2.50 x 10-8, right: 𝛽 = -11.83, p = 1.0x 10-6), so 
that individuals who stopped their responses more quickly activated this region more 
strongly. While there were no sex differences for SSRT (𝛽 = -1.532, p = 0.68), an 
interaction between sex and left putamen activation on SSRT (p = 0.009) was 
observed. Left putamen activation during response inhibition negatively correlated 
with SSRT in boys, not in girls (boys: 𝛽 = -16.97, βstand = -0.309, p = 10-10; girls: 𝛽 = -5.52, βstand = -0.112, p = 0.090).  
 
Reward anticipation 
In the fMRI reward anticipation task, we observed lesser activation in the putamen 
bilaterally in girls compared to boys (left: 𝛽  = -0.10, p = 5 x 10-6; right: 𝛽  = -0.090, p 
= 3.9 x 10-5). No significant main effect of rs945270 genotype on putamen activation 
was observed (𝛽  = 0.016, p = 0.66 and 𝛽  = 0.022, p = 0.38, for the left and right 
putamen, respectively). However, there was a significant sex-by-genotype interaction 
for activation in the right putamen (𝛽  = 0.084, p = 0.0065; bootstrapping p = 0.011; 
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meta-analysis, 𝛽  = 0.065, p = 0.0044; Left putamen: 𝛽 = 0.054, p = 0.086; Figure 
3A,B). Sex specific analyses indicated that putamen activation increased with the 
number of C-alleles at rs945270 in girls, most significantly in the right putamen (left: 𝛽  = 0.045, p = 0.035; right: 𝛽  = 0.066, p = 0.002). We performed post-hoc voxel-wise 
association analysis within the putamen to test if these effects of rs945270 on right 
putamen activation in girls were due to localized effects of rs945270 in the putamen. 
These identified significant clusters in the right anterior ventral putamen associating 
with rs945270 (Supplemental Figure S3, Supplemental Table S2). This indicates that 
rs945270 influences reward sensitivity in girls through localized effects on the right 
putamen. Analyses in boys did not reveal genotype differences (left: 𝛽= -0.009, p = 
0.71, right: 𝛽  = -0.019, p = 0.4). There were significant associations between 
putamen volume and putamen activation in this task (left: 𝛽  = 0.000085, p = 
0.000041, right: 𝛽= 0.000078, p = 0.00023), which were driven by girls (left: 𝛽 = 
0.00012, p = 0.000016, right: 𝛽 = 0.00011, p = 0.00007), not by boys. Besides, the 
associations between genotype and putamen activation remained significant after 
controlling for putamen volume. 
Given the reported decrease in ventral striatal activation during anticipation of 
reward in both adolescents and adults with ADHD 27-30, we investigated this link 
further in our sample. We found significant negative association between right 
putamen activation during reward anticipation and ADHD symptoms scores in the full 
sample (left: 𝛽  = -0.009, p = 0.089, right: 𝛽  = -0.012, p = 0.014). We found a 
negative trend for association between right putamen activation during reward 
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anticipation and ADHD symptoms in the full sample (left: 𝛽 = -0.009, p = 0.089, 
right: 𝛽 = -0.012, p = 0.014), reflecting an association with hyperactivity rather than 
inattention (Table 3). This suggests that the G-allele at rs945270 may partly 
contribute to the risk of ADHD through its negative effects on reward processing and 
positive effect on hyperactivity, particularly in girls. 
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Discussion 
Our study provides the first genetic link between putamen structure and function and 
risk for ADHD. We demonstrate that the rs945270 variant, identified in a previous 
genome-wide meta-analysis of putamen volume, associates with ADHD symptoms 
scores at age 14 years, notably with hyperactivity. We also found it may contribute to 
the genetic risk of ADHD by influencing neural mechanisms in a sex-specific manner. 
Specifically, the G-allele at this locus may partly contribute to the risk of ADHD in 
girls through its negative effects on reward processing in the right anterior ventral 
putamen and positive effect on hyperactivity. We also found that rs945270 genotypes 
affected putamen activation during successful response inhibition in boys, an effect 
that did not correlate with ADHD symptoms.  
 
  Our findings that a genetic polymorphism influences neural mechanisms related to 
ADHD (i.e., reward sensitivity) confirms previous evidence suggesting that a 
common set of genes may contribute to the distinct symptoms of ADHD 31. They also 
considerably extend these conclusions by providing a genetic mechanism that clarifies 
sexually dimorphic phenomena associated with ADHD 32. Sexual dimorphisms were 
evident during both response inhibition and reward anticipation, the putamen being 
activated to a lesser extent in girls compared to boys. The G-allele at rs945270 not 
only associated with higher scores of ADHD symptoms, it also accentuated sexually 
dimorphic responses by increasing putamen activity during response inhibition in 
boys and decreasing that in girls during reward anticipation. That girls carriers of the 
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risk G-allele at rs945270 exhibit significantly lowered putamen activation compared 
to carriers of the C-allele when anticipating a reward, suggests that this locus 
influences reward sensitivity in girls. The negative correlation between BOLD 
responses in the right putamen during reward anticipation and ADHD symptoms is 
indeed consistent with a blunted reward system, 29 as evidenced by 
hypo-responsiveness of the ventral striatum (VS) in ADHD patients 27, 28, 33, 34.  
   
Our voxel-wise analyses showing specific effects of rs945270 on the anterior and 
the posterior putamen in the reward- and motor response-related tasks, respectively 
provide further support earlier reports of putamen segmentation 35-38 indicating 
gradual functional specialization within the putamen. Rostral subregions are 
important for goal-direct behaviours, motivation and emotional processing, and 
higher-order cognitive aspects of motor function, such as learning new movements, 
through connections to the anterior cingulate cortex, pre-supplementary motor area, 
and prefrontal cortex 39. In contrast, more caudal regions are implicated in planning 
and execution of well-learned, skilled movements, through connections to primary 
and supplementary motor cortices 39, 40. A major implication of our study is that genes 
may impact these putamen-related functions differently in men and women. 
 
	   Our use of parental reports for the SDQ have a number of limitations. The SDQ 
has demonstrated reasonable efficiency in screening for ADHD in the community 26 
and it is notable that its hyperactivity/inattention scale performs similarly to the ‘any 
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disorder’ scale despite its brevity. However, this screening efficiency depends on the 
informant, with the combination of parents and teachers reports being a better 
predictor of ADHD. Thus, our use of single informant limited our ability to detect 
ADHD symptoms. It has also limited our ability to properly measure the impact of 
emotional disorders, which are better captured by self-reports. These limitations are 
further exacerbated by the poor ability of the SDQ to identify other disorders such as 
specific phobias, panic disorder/agoraphobia, eating disorders and separation 
anxiety. Thus, comorbidity and other unmeasured covariates, such as socio-economic 
status, parental psychopathology and life events could have contributed to our 
findings. 
 
Nonetheless our findings illustrate the sex-dependant impact of a genetic 
variation on human brain function and potential implication for ADHD. Further 
studies of patients and their controls, taking the above limitations into account, are 
needed to determine if rs945270 can help the detection and classification of ADHD 
and its subtypes and disease outcome. 
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Table 1: Demographics split by tasks (MID and SST) and sex. Means, standard 
deviations are presented below (Mean ± SD). 
Reward Anticipation 
 
Successful inhibition 
 
 
 Boys  
(n = 543) 
Girls 
 (n = 586) 
Boys  
(n = 577) 
Girls 
 (n = 650) 
Age (in years) 14.4 ± 0.4 
 
14.4 ± 0.4 
 
14.4 ± 0.4 
 
14.4 ± 0.4 
 
Handedness* 84 L/A 
459 R  
62 L/A 
524 R 
78 L/A 
499 R 
62 L/A 
588 R 
rs945270 
genotypes 
GG: 103 
GC: 229 
CC: 211 
GG: 97 
GC: 302 
CC: 187 
GG: 107 
GC: 267 
CC: 203 
GG: 106 
GC: 336 
CC: 208 
ADHD 
Symptoms 
scores  
3.2 ± 2.2 2.4 ± 2.1 3.1 ± 2.3 2.4 ± 2.1 
L/A: Left-handed or ambidextrous, R: Right-handed. 
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Table 2: Associations of rs945270 and sex with ADHD symptoms.  
 
	   rs945270	  
(effect	  C-­‐allele)	  
Sex	  
	  
Sex	  *	  rs945270	  
ADHD	  symptoms	   𝛽  =	  -­‐0.21,	  
p	  =	  0.005	  
𝛽  =	  -­‐0.77,	  
p	  =	  1.12	  x	  10-­‐12	  
𝛽  =	  0.049,	  
p	  =	  0.71	  
Hyperactivity	   𝛽	   =	  -­‐0.126	  
p	  =	  0.005	  
𝛽	   =	  -­‐0.361	  
p	  =	  1.37	  x	  10-­‐8	  
na	  
Inattention	   	   𝛽	   =	  -­‐0.093	  
p	  =	  0.028*	  
𝛽	   =	  -­‐0.406	  
p	  =	  6.77	  x	  10-­‐12	  
na	  
Associations significant affect Bonferroni correction for multiple testing are in bold. *, 
nominally significant association; na, not assessed. 
 
Table 3: Associations of rs945270, sex on ADHD symptoms on putamen activation 
split by tasks (SST and MID).   
	  
SST	  
MID	  
	   Left	  
putamen	  
Right	   	  
putamen	  
Left	  putamen	   Right	  
putamen	  
rs945270	   	  
(effect	  C-­‐allele)	  
𝛽  =	  -­‐0.088,	  
p	  =	  0.0030	  
𝛽  =	  -­‐0.089	  
p	  =	  0.0018	  
𝛽  =	  0.016,	  
p	  =	  0.66 
𝛽  =	  0.022,	  
p	  =	  0.38 
Sex	   𝛽  =	  -­‐0.15,	  
p	  =	  0.002	  
𝛽  =	  -­‐0.084,	  
p	  =	  0.035	  
𝛽  =	  -­‐0.10,	  
p	  =	  5	  x	  10-­‐6 
𝛽  =	  -­‐0.090,	  
p	  =	  3.9	  x	  10-­‐5 
Sex	  *	  
rs945270	  
𝛽	   =	  0.16,	  
p	  =	  0.0080	  
𝛽  =	  0.087,	  
p	  =	  0.12	  
𝛽	   =	  0.054,	  
p	  =	  0.086 
𝛽  =	  0.084,	  
p	  =	  0.0065 
ADHD	  symptoms	   𝛽  =	  0.002	  
p	  =0.80	  
𝛽  =0.003	  
p	  =0.76	  
𝛽  =	  -­‐0.009,	  
p	  =	  0.089 
𝛽  =	  -­‐0.012,	  
p	  =	  0.014* 
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Hyperactivity	  
𝛽  =0.010	  
p	  =0.52	  
𝛽  =0.008	  
p	  =0.60	  
𝛽  =	  -­‐0.015,	   	  
p	  =	  0.072 
𝛽  =	  -­‐0.021,	   	  
p	  =	  0.013* 
Inattention	   	  
𝛽  =-­‐0.004	  
p	  =0.83	  
𝛽  =-­‐6.4*10-­‐5	  
p	  =0.99	  
𝛽  =	  -­‐0.011,	   	  
p	  =	  0.25 
𝛽  =	  -­‐0.016,	   	  
p	  =	  0.076 
Sex	  *	  ADHD	  
𝛽  =	  -­‐0.036,	  
p	  =	  0.06	  
𝛽  =	  -­‐0.02,	   	  
p	  =	  0.27	  
𝛽  =	  0.008,	   	  
p	  =	  0.45 
𝛽  =	  -­‐0.006,	   	  
p	  =	  0.55 
Sex	  *	  
Hyperactivity	  
𝛽  =-­‐0.033,	  
p	  =	  0.30	  
𝛽  =	  -­‐0.014,	   	  
p	  =	  0.64	  
𝛽  =0.006,	  
p	  =	  0.73	    
𝛽  =0.008,	  
p	  =	  0.64 
Sex	  *	  
Inattention	  
𝛽  =	  -­‐0.075,	   	  
p	  =	  0.028*	  
𝛽  =	  -­‐0.47,	   	  
p	  =	  0.15	  
𝛽  =	  0.018,	   	  
p	  =	  0.34 
𝛽  =	  -­‐0.01,	   	  
p	  =	  0.59 
Associations significant affect Bonferroni correction for multiple testing are in bold. *, 
nominally significant associations. 
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Figures 
Figure 1: A) Relationship between ADHD symptoms scores and rs945270 in 14 
year-old adolescents (error bars denote SEM). B) Forest plots of associations 
between ADHD symptoms scores and rs945270 in the 8 research sites and 
meta-analysis. The β values obtained at each research site are shown as black squares, 
and the ranges between upper and lower CI95s are shown as the black lines. The 
integrated β as well as its upper and lower CI95s were calculated from the 
meta-analysis by using the inversion of squared SEs as weight, and the result is 
illustrated as the black diamond, where the mean is indicated vertically and the range 
between upper and lower CI95s is indicated horizontally. 
 
Figure 2: Relationship between rs945270 genotypes and BOLD responses within the 
left (A) and right (B) putamen during successful inhibition of motor response in the 
SST fMRI task (blue and red represent boys and girls, respectively, error bars denote 
SEM).  
 
Figure 3: BOLD responses within the left (A) and right (B) putamen during reward 
anticipation in the MID fMRI task stratified by rs945270 genotypes (blue and red 
represent boys and girls, respectively, error bars denote SEM).  
 
 
 
 
